Strangvac is a recombinant vaccine built on 8 fragments of the genome of Streptococcus equi, the organism responsible for the highly transmissible strangles infection. Initially approved in Europe in 2021, the vaccine is now reportedly entering trials in the United States as a step toward regulatory review. Läs mera i Equine Vet…